Pharming Group NV (PHAR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $16.37
• Market Cap: $1.17B
• 52-Week High: $21.34
• 52-Week Low: $7.50

Market Sentiment

Pharming Group NV currently has a Neutral sentiment score of 0.08.

About Pharming Group NV

Pharming Group NV is a leading specialty pharmaceutical company based in Leiden, the Netherlands, committed to developing innovative therapies for rare diseases and unmet medical needs worldwide. Utilizing its proprietary recombinant DNA technology, Pharming produces safe and effective treatments with a significant focus on improving patient outcomes. The company's strong presence in the United States and Europe underscores its dedication to addressing critical health challenges, providing ac...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Pharming Group NV and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PHAR pay dividends?

Pharming Group NV (PHAR) does not currently pay a regular dividend.

What is PHAR's market cap?

Pharming Group NV (PHAR) has a market capitalization of $1.17B with a current stock price of $16.37.